154.39 USD
↘ 2.63 (1.67%)AT CLOSE (03:59 PM EST)
Revvity, Inc.
RVTYNYSE • USD
154.72
↗ 0.33 (0.21%)
POST MARKET (AS OF 07:43 PM EST)
Post Market
AS OF 07:43 PM EST
154.72
↗ 0.33 (0.21%)
Market: CLOSED
Shares of Revvity, Inc. (RVTY) are trading at $154.52. There is a divergence between signals — underlying fundamentals rate "Buy" but technical indicators lean "Sell". Notable factors include a robust Altman Z-Score and a bullish Golden Cross on the moving averages. Valuation metrics place RVTY at a fair price relative to peers.
Technical & fundamental data as of Nov 13, 2026.
Open?$160.17
High?$160.59
Low?$151.06
Prev. Close?$157.02
Volume?1.3M
Avg. Volume?1.8M
VWAP?$154.27
Rel. Volume?0.72x
Bid / Ask
Bid?$150.00 × 100
Ask?$160.20 × 100
Spread?$10.20
Midpoint?$155.10
Valuation & Ratios
Market Cap?17.5B
Shares Out?111.6M
Float?111.1M
Float %?99.6%
P/E Ratio?69.23
P/B Ratio?2.41
EPS?$2.27
Dividend?0.18%
Ex-Dividend?2027-01-22
News
Profile
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Themes
Employees
11.0K
Market Cap
17.5B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
Listed
1972-06-01
Address
77 4TH AVENUE
WALTHAM, MA 02451
Phone: 781-663-6900
WALTHAM, MA 02451
Phone: 781-663-6900
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?88
Momentum?82
Short Sent.?69
Piotroski F-Score?6/9Mixed
Altman Z-Score?3.73Safe
Confidence?81%High
Short InterestElevated
Short % of Float?5.87%Elevated
Short Interest?6.5M
Days to Cover?3.9
Free Float111.1M
Avg Daily Volume1.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.65Strong
Quick Ratio?2.10Strong
Cash Ratio?0.85Adequate
Debt/Equity?0.36Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score56/100
P/E?69.2PRICEY▾
Peers30
S&P7
P/B?2.41CHEAP▾
Peers91
S&P66
P/S?5.96FAIR▾
Peers55
S&P22
P/FCF?29.7FAIR▾
Peers82
S&P30
EV/EBITDA?24.9HIGH▾
Peers55
S&P16
EV/Sales?6.65HIGH▾
Peers55
S&P23
Returns & Efficiency
ROE?3.5%WEAK▾
Peers30
S&P18
ROA?2.2%WEAK▾
Peers30
S&P21
Cash Flow & Enterprise
FCF?$590.5M
Enterprise Value?$19.6B
Fundamentals ratios updated end of day